Loading…
Pharmaceutical Market Access and Drug Safety Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
66pct
23d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · first_quarter · Health Issues
S. 251, Pharmaceutical Market Access Act of 2007; S. 242/H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007; S. 2029/H.R. 5605, Physician Payment Sunshine Act of 2008; S. 558, Mental Health Parity Act of 2007; H.R. 1424, Paul Wellstone Health and Addiction Equity Act of 2007; S. 2723/H.R. 5549, Deamonte Driver Dental Access Act of 2008; H.R. 3580 - Food and Drug Administration Amendments Act of 2007
Client expense: $733,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2008 · fourth_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Medicaid/Targeted Case Management (continued). Reduction Act.
2008 · third_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: Medicare/General (continued). provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicare/Identity Theft Prevention. H.R. 6600, provisions related to removal of Social Security numbers from Medicare cards. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Reduction Act.
2008 · second_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: Interim final rule to implement Section 6052 of the Deficit Reduction Act.
2008 · first_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, Medicare Secondary Payer clarification, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Reduction Act.
| Democratic |
| NY |
| Barney Frank | Democratic | MA |
| Barton Gordon | Democratic | TN |
| Ben Chandler | Democratic | KY |
| Betty McCollum | Democratic | MN |
| Betty Sutton | Democratic | OH |
| C. A. Dutch Ruppersberger | Democratic | MD |
| Carol Shea-Porter | Democratic | NH |
| Carolyn McCarthy | Democratic | NY |
| Charles Wilson | Democratic | OH |
| Chris Van Hollen | Democratic | MD |
| Christopher Carney | Democratic | PA |
| Christopher Murphy | Democratic | CT |
| Christopher Shays | Republican | CT |
| Collin C. Peterson | Democratic | MN |
| Dale E. Kildee | Democratic | MI |
| Dan Burton | Republican | IN |
| Daniel Lipinski | Democratic | IL |
| Darlene Hooley | Democratic | OR |
| David Wu | Democratic | OR |
| Debbie Wasserman Schultz | Democratic | FL |
| Dennis Moore | Democratic | KS |
| Doc Hastings | Republican | WA |
| Donald Payne | Democratic | NJ |
| Earl Blumenauer | Democratic | OR |
| Ed Pastor | Democratic | AZ |
| Elijah E. Cummings | Democratic | MD |
| Emanuel Cleaver | Democratic | MO |
| Fortney Pete Stark | Democratic | CA |
| Frank R. Wolf | Republican | VA |
| Frederick Boucher | Democratic | VA |
| Gabrielle Giffords | Democratic | AZ |
| Gary L. Ackerman | Democratic | NY |
| Gene Green | Democratic | TX |
| Gene Taylor | Democratic | MS |
| George Miller | Democratic | CA |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Hilda Solis | Democratic | CA |
| Howard L. Berman | Democratic | CA |
| James Marshall | Democratic | GA |
| James Oberstar | Democratic | MN |
| James P. McGovern | Democratic | MA |
| James P. Moran | Democratic | VA |
| James Ramstad | Republican | MN |
| Jane Harman | Democratic | CA |
| Janice D. Schakowsky | Democratic | IL |
| Jason Altmire | Democratic | PA |
| Jerrold Nadler | Democratic | NY |
| Jerry F. Costello | Democratic | IL |
| Jerry McNerney | Democratic | CA |
| Jim Cooper | Democratic | TN |
| Jim Costa | Democratic | CA |
| Jo Ann Emerson | Republican | MO |
| John Barrow | Democratic | GA |
| John F. Tierney | Democratic | MA |
| John Hall | Democratic | NY |
| John Lewis | Democratic | GA |
| John Murtha | Democratic | PA |
| John W. Olver | Democratic | MA |
| Julia Carson | Democratic | IN |
| Kathy Castor | Democratic | FL |
| Keith Ellison | Democratic | MN |
| Linda T. Sánchez | Democratic | CA |
| Louise McIntosh Slaughter | Democratic | NY |
| Luis V. Gutiérrez | Democratic | IL |
| Lynn C. Woolsey | Democratic | CA |
| Marcy Kaptur | Democratic | OH |
| Marilyn Musgrave | Republican | CO |
| Martin Meehan | Democratic | MA |
| Maurice D. Hinchey | Democratic | NY |
| Mazie K. Hirono | Democratic | HI |
| Melissa Bean | Democratic | IL |
| Michael K. Simpson | Republican | ID |
| Michael McNulty | Democratic | NY |
| Neil Abercrombie | Democratic | HI |
| Nita M. Lowey | Democratic | NY |
| Patrick Murphy | Democratic | PA |
| Paul Kanjorski | Democratic | PA |
| Peter A. DeFazio | Democratic | OR |
| Peter Hoekstra | Republican | MI |
| Peter Welch | Democratic | VT |
| Phil Hare | Democratic | IL |
| Rick Larsen | Democratic | WA |
| Robert Berry | Democratic | AR |
| Robert Wexler | Democratic | FL |
| Rosa L. DeLauro | Democratic | CT |
| Roscoe G. Bartlett | Republican | MD |
| Rubén Hinojosa | Democratic | TX |
| Russ Carnahan | Democratic | MO |
| Shelley Berkley | Democratic | NV |
| Silvestre Reyes | Democratic | TX |
| Steve Cohen | Democratic | TN |
| Steve Israel | Democratic | NY |
| Steve Kagen | Democratic | WI |
| Steven C. LaTourette | Republican | OH |
| Thomas Allen | Democratic | ME |
| Thomas E. Petri | Republican | WI |
| Tim Holden | Democratic | PA |
| Timothy H. Bishop | Democratic | NY |
| Todd Russell Platts | Republican | PA |
| Tom Lantos | Democratic | CA |
| Victor Snyder | Democratic | AR |
| Virginia Brown-Waite | Republican | FL |
| Walter B. Jones | Republican | NC |
| William Delahunt | Democratic | MA |
| Zach Wamp | Republican | TN |
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $480,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 4854 False Claims Act Correction Act of 2007 S. 2029 False Claims Act Correction Act of 2007 H.R. 4703 Vaccine Shortage Preparedness Act of 2008 S. 2467 Vaccine Shortage Preparedness Act of 2008 S. 2476 Improved Vaccines Supply Act H.R. 3944 National Hepatitis B Act H.R. 5884 Sunshine in Litigation Act of 2008 S. 2449 Sunshine in Litigation Act of 2007 H.R. 5605 Physician Payments Sunshine Act of 2008 S. 2029 Physician Payments Sunshine Act of 2007 H.R. 3610 Food and Drug Import Safety Act of 2007 S. 3409 Drug and Device Accountability Act of 2008 H.R. 6381 Medical Device Safety Act of 2008 S. 3398 Medical Device Safety Act of 2008
Client expense: $2,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 4854 False Claims Act Correction Act of 2007 S. 2029 False Claims Act Correction Act of 2007 H.R. 4703 Vaccine Shortage Preparedness Act of 2008 S. 2467 Vaccine Shortage Preparedness Act of 2008 S. 2476 Improved Vaccines Supply Act H.R. 3944 National Hepatitis B Act H.R. 5884 Sunshine in Litigation Act of 2008 S. 2449 Sunshine in Litigation Act of 2007 H.R. 5605 Physician Payments Sunshine Act of 2008 S. 2029 Physician Payments Sunshine Act of 2007 H.R. 3610 Food and Drug Import Safety Act of 2007 S. 3409 Drug and Device Accountability Act of 2008 H.R. 6381 Medical Device Safety Act of 2008 S. 3398 Medical Device Safety Act of 2008
Client expense: $2,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Budget/Appropriations
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
HR.380, Pharmaceutical Market Access and Drug Safety Act of 2007 S.242, Pharmaceutical Market Access and Drug Safety Act of 2007 HR.2900, Food and Drug Administration Amendments Act of 2007 Diabetes treatment Comparative effectiveness Pharmaceutical import safety legislation Health care reform
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics Neglected Disease Issues Issues related to Drug Safety, Generic Biologics & Drug Approvals H.R. 380, "Pharmaceutical Market Access and Drug Safety Act of 2007" - Importation. S.251, Pharmaceutical Market Access & Drug Safety Act of 2007" - Importation. S.242, "Pharmaceutical Market Access & Drug Safety Act of 2007" H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007 H.R. 3610 Food and Drug Import Safety Act of 2007 S. 4, Improving America's Security Act of 2007, cargo-screening provision
Client expense: $658,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
H.R. 380/S. 242/S. 251, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. S. 596, to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of Internet pharmacies.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · third_quarter · Pharmacy
H.R. 380/S. 242/S. 251, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. S. 596, to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of Internet pharmacies.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · fourth_quarter · Health Issues
HR 380, S 623, Access to Life-Saving Medicine Act; Follow-on biologics, importation; HR 3610 Food and Drug Import Safety Act of 2007; Import safety; HR 5839, Safeguard Americans Pharmaceuticals Act; S 2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption. HR 1038, Access to Life-Saving Medicine Act; follow-on biologics; H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007; follow-on biologics; HR 3610, Food and Drug Import Safety Act of 2007: import safety HR 6151, Responsibilty in Drug and Device Advertising Act of 2008: Direct-to-consumer advertising; S 242, Pharmaceutical Market Acess and Drug Safety Act of 2007: importation; S 334, Healthy Americans Act: non-interference; S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs; S 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics; S 2663, CPSC Reform Act: importation; S 3398, Medical Device Safety Act of 2008: preemption issues; S 3409, Drug and Device Accountability Act of 2008: import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Health Issues
S. 242/H.R. 380- Pharmaceutical Market Access and Drug Safety Act of 2007- entire bill. S. 586/H.R. 1968- Community Health Workers Act of 2007- entire bill. S. 980/H.R. 6353- Online Pharmacy Consumer Protection Act of 2007- entire bill. S. 1240/H.R. 464- Compassionate Assistance for Rape Emergencies Act of 2007- entire bill. S. 1375- Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act/MOTHERS Act- entire bill. S. 1376/H.R. 2606- 340B Program Improvement and Integrity Act of 2007- entire bill. S. 2347/H.R. 4054- Prevention Through Affordable Access Act- entire bill. S. 1555/H.R. 2596- Access to Birth Control Act- entire bill. S.1800/H.R. 2064- Compassionate Care for Servicewomen Act- entire bill. S. 2731/ H.R. 5501- The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008- provisions related to family planning, sex education, abstinence, and abortion. H.R. 20- Melanie Blocker-Stokes Postpartum Depression Research and Care Act- entire bill. H.R. 1424- Paul Wellstone Mental Health and Addiction Equity Act of 2007- potential provision related to abortion and possible provision related to nominal drug pricing. H.R. 3014- The Health Equity and Accountability Act of 2007- entire bill. H.Res. 1131- Recognizing that the Centers for Disease Control and Prevention observes the month of April as National STD Awareness Month and urging the House of Representatives to focus greater attention on activities related to the prevention of STDs and screening and treatment for STDs- entire resolution. H.R. 6357- Protecting Records, Optimizing Treatment, and Easing Communication Through Health Care Technology Act- provisions on health care technology transition. H.R. 6100/S. 3040- Kid-Safe Chemicals Act of 2008- entire bill. H.R. 6906- H.I.V. Education and Prevention Act of 2008- entire bill. H.R. 6680- Community AIDS and Hepatitis Prevention Act- entire bill. H.R. 6358- Stop Abuse in Residential Treatment Programs Act of 2008- provision related to contraceptive access. H.R. 1237/S. 2510- Cytology Proficiency Improvement Act of 2008- entire bill. S. 20/ H.R. 7310- Protecting Patients and Health Care Act- entire bill. H.R. 7296- Midnight Rule Act- provision relating to the Department of Health and Human Services physician conscience regulation. S. 3297- Advancing Americas Priorities Act- provision related to nominal drug pricing. H.Con.Res. 400- Expressing the support of the Congress regarding the need to ensure health care for women and health care for all in national health care reform- entire resolution.
Client expense: $121,667 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
Client expense: $6,170,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · fourth_quarter · Medicare/Medicaid
H.R. 3162, The Children's Health and Medicare Protection (CHAMP) Act of 2007 S. 2499, The Medicare, Medicaid and SCHIP Extension Act of 2007 H.R. 380/S. 242, Pharmaceutical Market Access Act of 2007 H.R. 1218, Medicare Prescription Drug Improvement Act of 2007
Client expense: Not reported · Firm income: $120,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 4854 False Claims Act Correction Act of 2007 S. 2029 False Claims Act Correction Act of 2007 H.R. 4703 Vaccine Shortage Preparedness Act of 2008 S. 2467 Vaccine Shortage Preparedness Act of 2008 S. 2476 Improved Vaccines Supply Act H.R. 3944 National Hepatitis B Act H.R. 5884 Sunshine in Litigation Act of 2008 S. 2449 Sunshine in Litigation Act of 2007 H.R. 5605 Physician Payments Sunshine Act of 2008 S. 2029 Physician Payments Sunshine Act of 2007 H.R. 3610 Food and Drug Import Safety Act of 2007 S. 3409 Drug and Device Accountability Act of 2008 H.R. 6381 Medical Device Safety Act of 2008 S. 3398 Medical Device Safety Act of 2008
Client expense: $2,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
S. 2029, Physicians Payment Sunshine Act: reporting periodicity, reporting amount, pre-emption. S. 558, Mental Health Parity Act of 2997: Medicaid rebate. H.R.380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation. H.R.1038, Access to Life Saving Medicine Act: follow-on biologics. H.R.3610, Food and Drug Import Safety Act of 2007: import safety. H.R. 5629, Pathway for Biosimilars Act: follow-on biologics. S.242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation. S.623, Access to Life-Saving Medicine Act: follow-on biologics. S.1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medicare/Medicaid
Medicare/General. H.R. 205, H.R. 748, H.R. 1218, H.R. 1277, H.R. 1310, H.R. 1521, H.R. 2009, H.R. 2056, H.R. 2065, H.R. 2149, H.R. 3025, H.R. 3061, H.R. 3162, H.R. 3932, H.R. 6331, S. 137, S. 250, S. 450, S. 706, S. 1887, S. 2089, S. 2115, S. 2219, S. 3101: provisions relating to enrollment periods and the late enrollment penalty, physician reimbursement rates, creating a Medicare-operated prescription drug plan, drug price negotiations, Medicare beneficiary improvements, repealing cost containment mandates, Medicare Advantage payments, Medicare Advantage stabilization fund, and comparative cost adjustment demonstration projects under the Medicare Modernization Act, therapy caps, liberalizing asset test limits, reducing the Part D benefit gap and guaranteeing prescription drug benefits. Medicare/Prescription Drug Price Negotiation. H.R. 4, H.R. 118, H.R. 5317, S. 3, S. 273: provisions pertaining to the negotiation of prescription drug prices under Medicare Part D. Medicare/Medicare Advantage. H.R. 2945: provision to provide beneficiary protections against excessive cost-sharing under the Medicare Advantage Program. Medicare/Importation of Prescription Drugs. S. 242, H.R. 380, S.Amdt. 4299: provisions pertaining to the importation of prescription drugs. Medicare/Outpatient Psychiatric Services. H.R. 1571, H.R. 1663, H.R. 4897, S. 1715, S. 1854: provisions to eliminate discriminatory copayment rates for outpatient psychiatric services under Medicare Part B. Medicare/Geriatric Assessments. H.R. 2244, S. 1340: provisions to provide Medicare beneficiaries with access to geriatric assessments and chronic care coordination services. Medicare/Generic Drugs Market Exclusivity. H.R. 1432, H.R. 1902, S. 316, S. 1088: pertaining to market exclusivity for generic drugs. Medicare/Prescription Drug Benefits for Low Income Beneficiaries. H.R. 470, H.R. 932, H.R. 1536, H.R. 2058, H.R. 3127, S. 1102, S. 1103, S. 1107, S. 1108, S. 2101: provisions affecting prescription drug benefits for low-income beneficiaries under Medicare Parts B and D. Medicare/Part B Late Enrollment. H.R. 2591: provision limiting the penalty for late enrollment under Medicare Part B. Medicare/Marketing. H.R. 2307, H.R. 4790, S. 1883, S. 2687: provisions relating to the marketing of Medicare Advantage and Medicare Part D plans. Medicare/Health Care Vouchers. H.R. 749: provision to establish health care vouchers for seniors. Medicare/Medicare Savings Accounts. H.R. 2639, S. 173, S. 1019: provisions pertaining to Medicare Savings Accounts. Medicare/End-of-Life Planning. S. 464, S. 465, S. 466: pertaining to advance directives and end-of-life planning. Medicare/Means-testing. H.R. 4295, H.R. 4330, S. 2414, S.Amdt. 4240: pertaining to means-testing of Medicare Part D. Medicare/Presidents Funding Warning. H.R. 5480, S. 2662: proposals responding to the Presidents Medicare funding warning. H. Res. 1368, to suspend section 803 of the Medicare Modernization Act of 2003 (known as the Medicare trigger") for the remainder of the 110th Congress. Medicare/24-month Waiting Period. H.R.154, S. 2101: provisions phasing out the 24-month waiting period for disabled individuals to become eligible for Medicare benefits and eliminating the waiting period for individuals with life-threatening conditions. Medicaid/Federal Match. H.R. 5140: provisions pertaining to temporary increases in the federal Medicaid match. Medicaid/Targeted Case Management. Targeted Case Management: interim final rule to implement Section 6052 of the Deficit Medicaid/Targeted Case Management (continued). Reduction Act.
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor. S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor. S.554: Act For Our Kids - Track and monitor. HR 380: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. S. 242: Pharmaceutical Market Access and Drug Safety Act of 2007 - Track and monitor. H.R. 6353: Ryan Haight Online Pharmacy Consumer Protection Act of 2008 - Track and monitor.
Client expense: Not reported · Firm income: $7,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Follow-on biologics: Access to Life-Saving Medicine Act (HR 1038); Patient Protection and Innovative Biologic Medicines Act (HR 1956); Biologics Price Competition and Innovation Act (S. 1695); Pathway for Biosimilars Act (HR 5629). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9) Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Follow-on biologics: Access to Life-Saving Medicine Act (HR 1038); Patient Protection and Innovative Biologic Medicines Act (HR 1956); Biologics Price Competition and Innovation Act (S. 1695); Pathway for Biosimilars Act (HR 5629). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S 1893, Children's Health Insurance Program Reauthorization Act of 2007 (Expansion/extension of SCHIP ); S558/HR 1424, Mental Health Parity Act of 2007 (Secure equal treatment for mental health benefits); HR 1038/S 623, Access to Life-Saving Medicine Act (Biogenerics-approving generic Bio pharmaceuticals); S 316, Preserve Access to Affordable Generics Act (Regulate Generic/Brand patent settlements); S 1501/S 1695, Affordable Biologics for Consumers Act (Generic Bio-pharmaceuticals); S 334, Healthy Americans Act (Universal health coverage replaces employer coverage); S 1899, Universal Health Coverage Act of 2007 (Mandatory health insurance coverage); S 242/HR 380, Pharmaceutical Market Access and Drug Safety Act of 2007 (Drug importation-Canada, et al.); HR 1076/S616, HIPAA Recreational Injury Technical/Correction Act (Mandatory coverage for recretional activity); HR 676, United States National Health Insurance Act (National health insurance); HR 1368, Personalized Health Information Act of 2007 (Financial incentives for personal health records); S 1490, Federal Employees Electronic Personal Health Records Act of 2007 (health information technology); S 1544, Medicare Quality Enhancement Act of 2007 (CMS data release); S 1693, Wired for Health Care Quality Act (Health information technology); HR 1368, Personalized Health Information Act of 2007; HR 5422, TRUST in Health Information Act of 2008; S 1693, Wired for Health Care Quality Act; S 1814, Health Information Privacy and Security Act; HR 6357, ProTecht Act of 2008; HR 6898, Health Information Technology Act of 2008; HR 6582, Small Business Choice Act of 2008; S 2795, SHOP Act; HR 6210, SHOP Act; S 2818, Small Busienss Health Plans Act of 2008.
Client expense: $517,594 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2008 · second_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 194 and H.R. 380, In support of Medicare Part D Improvement: H.R. 2056, In support of Medicare Part B Means Testing Elimination: H.R. 4330
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2008 · third_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 194 and H.R. 380, In support of Medicare Part D Improvement: H.R. 2056, In support of Medicare Part B Means Testing Elimination: H.R. 4330
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2008 · fourth_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 194, and H.R. 380; In support of Medicare Part D Improvement: H.R. 2056; In support of Medicare Part B Means Testing Elimination: H.R. 4330; In support of Social Security Notch Reform: H.R. 368
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES
2008 · fourth_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 194 and H.R. 380, In support of Medicare Part D Improvement: H.R. 2056, In support of Medicare Part B Means Testing Elimination: H.R. 4330
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,070,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · third_quarter · Health Issues
HR 380, S 623, Access to Life-Saving Medicine Act; Follow-on biologics; HR 3610 Food and Drug Import Safety Act of 2007; Import safety; HR 5839, Safeguard Americans Pharmaceuticals Act; S 2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
H.R.5839, Safeguarding America's Pharmaceuticals Act S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: $205,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Pharmacy
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics Neglected Disease Issues Issues related to Drug Safety, Generic Biologics & Drug Approvals H.R. 380, "Pharmaceutical Market Access and Drug Safety Act of 2007" - Importation. S.251, Pharmaceutical Market Access & Drug Safety Act of 2007" - Importation. S.242, "Pharmaceutical Market Access & Drug Safety Act of 2007" H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007 H.R. 3610 Food and Drug Import Safety Act of 2007 S. 4, Improving America's Security Act of 2007, cargo-screening provision
Client expense: $770,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Consumer Issues/Safety/Products
HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07
Client expense: $3,060,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
2008 · third_quarter · Pharmacy
H.R. 380/S. 242/S. 251, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. S. 596, to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of Internet pharmacies.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · third_quarter · Health Issues
S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 4854 False Claims Act Correction Act of 2007 S. 2029 False Claims Act Correction Act of 2007 H.R. 4703 Vaccine Shortage Preparedness Act of 2008 S. 2467 Vaccine Shortage Preparedness Act of 2008 S. 2476 Improved Vaccines Supply Act H.R. 3944 National Hepatitis B Act H.R. 5884 Sunshine in Litigation Act of 2008 S. 2449 Sunshine in Litigation Act of 2007 H.R. 5605 Physician Payments Sunshine Act of 2008 S. 2029 Physician Payments Sunshine Act of 2007 H.R. 3610 Food and Drug Import Safety Act of 2007 S. 3409 Drug and Device Accountability Act of 2008 H.R. 6381 Medical Device Safety Act of 2008 S. 3398 Medical Device Safety Act of 2008
Client expense: $1,950,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Health Issues
S. 2029/H.R. 5605, Physician Payment Sunshine Act of 2008; S. 558, Mental Health Parity Act of 2007; H.R. 1424, Paul Wellstone Health and Addiction Equity Act of 2007; S. 2723/H.R. 5549, Deamonte Driver Dental Access Act of 2008; H.R. 493, Genetic Information Nondiscrimination Act of 2008; H.R. 3195 - ADA Restoration Act of 2007; H.R. 6357, Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 S. 251, Pharmaceutical Market Access Act of 2007; S. 242/H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 HR. 2851 Michelle's Law
Client expense: $794,730 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2008 · third_quarter · Health Issues
HR 380 Pharmaceutical Market Access and Drug Safety Act of 2007 HR 676 United States National Health Insurance Act S 400 Michelle's Law HR 840 Homeless Emergency Assistance and Rapid Transition to Housing Act of 2008 Whose Side are you On Campaign
Client expense: $541,199 · Firm income: Not reported
Government targets: Education, Dept of, Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1014, Heart Disease Education, Analysis Research, and Treatment for Women Act: reporting and analysis of patient data H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: direct-to-consumer drug advertising H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008: on-line pharmacy issues H.R. 6378, Strengthening of FDA Integrity Act of 2008: debarment H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6432, Animal Drug User Fee Amendments of 2008: technical corrections to FDAAA H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
Client expense: $5,420,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · third_quarter · Health Issues
HR.380, Pharmaceutical Market Access and Drug Safety Act of 2007 S.242, Pharmaceutical Market Access and Drug Safety Act of 2007 HR.2900, Food and Drug Administration Amendments Act of 2007 Diabetes treatment Comparative effectiveness Pharmaceutical import safety legislation
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
S 1893, Children's Health Insurance Program Reauthorization Act of 2007 (Expansion/extension of SCHIP ); S558/HR 1424, Mental Health Parity Act of 2007 (Secure equal treatment for mental health benefits); HR 1038/S 623, Access to Life-Saving Medicine Act (Biogenerics-approving generic Bio pharmaceuticals); S 316, Preserve Access to Affordable Generics Act (Regulate Generic/Brand patent settlements); S 1501/S 1695, Affordable Biologics for Consumers Act (Generic Bio-pharmaceuticals); S 334, Healthy Americans Act (Universal health coverage replaces employer coverage); S 1899, Universal Health Coverage Act of 2007 (Mandatory health insurance coverage); S 242/HR 380, Pharmaceutical Market Access and Drug Safety Act of 2007 (Drug importation-Canada, et al.); HR 1076/S616, HIPAA Recreational Injury Technical/Correction Act (Mandatory coverage for recretional activity); HR 676, United States National Health Insurance Act (National health insurance); HR 1368, Personalized Health Information Act of 2007 (Financial incentives for personal health records); S 1490, Federal Employees Electronic Personal Health Records Act of 2007 (health information technology); S 1544, Medicare Quality Enhancement Act of 2007 (CMS data release); S 1693, Wired for Health Care Quality Act (Health information technology); HR 1368, Personalized Health Information Act of 2007; HR 5422, TRUST in Health Information Act of 2008; S 1693, Wired for Health Care Quality Act; S 1814, Health Information Privacy and Security Act; HR 6357, ProTecht Act of 2008; HR 6898, Health Information Technology Act of 2008; HR 6582, Small Business Choice Act of 2008; S 2795, SHOP Act; HR 6210, SHOP Act; S 2818, Small Busienss Health Plans Act of 2008.
Client expense: $452,449 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2008 · third_quarter · Pharmacy
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Health Issues
S. 242/H.R. 380- Pharmaceutical Market Access and Drug Safety Act of 2007- entire bill. S. 586/H.R. 1968- Community Health Workers Act of 2007- entire bill. S. 980/H.R. 6353- Online Pharmacy Consumer Protection Act of 2007- entire bill. S. 1240/H.R. 464- Compassionate Assistance for Rape Emergencies Act of 2007- entire bill. S. 1375- Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act/MOTHERS Act- entire bill. S. 2347/H.R. 4054- Prevention Through Affordable Access Act- entire bill. S. 1555/H.R. 2596- Access to Birth Control Act- entire bill. S.1790/H.R. 468- Communities of Color Teen Pregnancy Prevention Act of 2007- entire bill. S.1800/H.R. 2064- Compassionate Care for Servicewomen Act- entire bill. S. 2731/ H.R. 5501- The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008- provisions related to family planning, sex education, abstinence, and abortion. H.R. 20- Melanie Blocker-Stokes Postpartum Depression Research and Care Act- entire bill. H.R. 1424- Paul Wellstone Mental Health and Addiction Equity Act of 2007- potential provision related to abortion and possible provision to provide a fix for nominal drug pricing. H.R. 3014- The Health Equity and Accountability Act of 2007- entire bill. H.R. 6331- Medicare Improvements for Patients and Providers Act of 2008- provision related to drug pricing, 340B program and Title V abstinence education funding. H.Res.1131- Recognizing that the Centers for Disease Control and Prevention observes the month of April as National STD Awareness Month and urging the House of Representatives to focus greater attention on activities related to the prevention of STDs and screening and treatment for STDs- entire resolution. HR 1157- The Breast Cancer and Environmental Research Act- entire bill. H.R. 6353- Ryan Haight Online Pharmacy Consumer Protection Act of 2008- entire bill. H.R. 6100/S. 3040- Kid-Safe Chemicals Act of 2008- provisions affecting reproductive health. H.R. 6906- H.I.V. Education and Prevention Act of 2008- entire bill. H.R. 6680- Community AIDS and Hepatitis Prevention Act- entire bill. H.R. 6358- Stop Abuse in Residential Treatment Programs Act of 2008- provision related to possible restrictions on contraceptive access. H.R. 1237/S 2510- Cytology Proficiency Improvement Act of 2008- entire bill. H.Con.Res. 400- Expressing the support of the Congress regarding the need to ensure health care for women and health care for all in national health care reform- entire bill.
Client expense: $278,579 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
S. 242/H.R. 380- Pharmaceutical Market Access and Drug Safety Act of 2007- entire bill. S. 586/H.R. 1968- Community Health Workers Act of 2007- entire bill. S. 1375- Mom's Opportunity to Access Health, Education, Research, and Support for Postpartum Depression Act/MOTHERS Act- entire bill. S. 2347/H.R. 4054- Prevention Through Affordable Access Act- entire bill. S. 1555/H.R. 2596- Access to Birth Control Act- entire bill. S.1790/H.R. 468- Communities of Color Teen Pregnancy Prevention Act of 2007- entire bill. S. 2731/ H.R. 5501- The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008- provisions related to family planning, sex education, abstinence, and abortion. H.R. 20- Melanie Blocker-Stokes Postpartum Depression Research and Care Act- entire bill. H.R. 1424- Paul Wellstone Mental Health and Addiction Equity Act of 2007- potential provision related to abortion and possible provision to provide a fix for nominal drug pricing. H.R. 3014- The Health Equity and Accountability Act of 2007- entire bill. H.R. 6331- Medicare Improvements for Patients and Providers Act of 2008- provision related to drug pricing, 340B program and Title V abstinence education funding. H.R. 6100/S. 3040- Kid-Safe Chemicals Act of 2008- provisions affecting reproductive health. H.R. 6358- Stop Abuse in Residential Treatment Programs Act of 2008- provision related to possible restrictions on contraceptive access. H.Con.Res. 400- Expressing the support of the Congress regarding the need to ensure health care for women and health care for all in national health care reform- entire bill.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
S. 2029, Physicians Payment Sunshine Act: reporting periodicity, reporting amount, pre-emption. S. 558, Mental Health Parity Act of 2997: Medicaid rebate. H.R.380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation. H.R.1038, Access to Life Saving Medicine Act: follow-on biologics. H.R.3610, Food and Drug Import Safety Act of 2007: import safety. H.R. 5629, Pathway for Biosimilars Act: follow-on biologics. S.242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation. S.623, Access to Life-Saving Medicine Act: follow-on biologics. S.1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug safety: Food and Drug Administration Amendments Act of 2007 (Public Law No: 110-85); Food and Drug Import Safety Act (HR 3610); Drug reimportation: Pharmaceutical Market Access Act (S. 251); Pharmaceutical Market Access and Drug Safety Act (S. 242/HR 380). Comparative Effectiveness: Comparative Effectiveness Research Act (S. 3408); Enhanced Health Care Value for All Act (HR 2184).
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE